C. Fortner

发表

Comparison of basic infection prevention techniques, with standard room reverse isolation or with reverse isolation plus added air filtration

P. Wiernik, S. Schimpff, V. M. Young, 1978 .

Infection in Acute Leukemia Patients Receiving Oral Nonabsorbable Antibiotics

P. Wiernik, S. Schimpff, V. M. Young, 1978, Antimicrobial Agents and Chemotherapy.

Fat emulsion vehicle for intravenous administration of an aqueous insoluble drug.

C. Fortner, W. Grove, D. Bowie, 1975, American journal of hospital pharmacy.

Current Therapeutic Concepts—Carcinoma of the Breast

C. Fortner, W. Grove, 1976 .

A comparison of trimethoprim-sulfamethoxazole plus nystatin with gentamicin plus nystatin in the prevention of infections in acute leukemia.

P. Wiernik, S. Schimpff, J. Wade, 1981, The New England journal of medicine.

Hypersensitivity reactions to teniposide (VM-26): an analysis.

B. Leyland-Jones, P. O'dwyer, S. A. King, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Review of amsacrine, an investigational antineoplastic agent.

P. Wiernik, C. Fortner, W. Grove, 1982, Clinical pharmacy.

Cost analysis of leukemia treatment. A problem‐oriented approach

H. Shapiro, V. Vogel, P. Wiernik, 1976, Cancer.

Cisplatin Nephrotoxicity: A Summary of Preventative Interventions

R. Finley, C. Fortner, W. Grove, 1985, Drug intelligence & clinical pharmacy.

Meperidine for the treatment of shaking chills and fever.

J. Aisner, P. Wiernik, C. Fortner, 1980, Archives of internal medicine.

Amikacin and Cephalothin: Empiric Regimen for Granulocytopenic Cancer Patients

H. Standiford, P. Wiernik, S. Schimpff, 1977, Antimicrobial Agents and Chemotherapy.

A comparative trial of tobramycin vs gentamicin in combination with vancomycin and nystatin for alimentary tract suppression in leukemic patients.

J. Bender, P. Wiernik, S. Schimpff, 1979, European journal of cancer.

Randomized trial of empiric antibiotic therapy with ticarcillin in combination with gentamicin, amikacin or netilmicin in febrile patients with granulocytopenia and cancer.

J. Bender, H. Standiford, P. Wiernik, 1979, The American journal of medicine.

Randomized clinical comparison of daunorubicin (NSC-82151) alone with a combination of daunorubicin, cytosine arabinoside (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemia.

M. O’connell, C. Schiffer, J. Aisner, 1976, Cancer treatment reports.

Infection prevention in acute nonlymphocytic leukemia. Laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis.

P. Wiernik, S. Schimpff, J. Block, 1975, Annals of internal medicine.

Potential of mezlocillin as empiric single-agent therapy in febrile granulocytopenic cancer patients

P. Wiernik, S. Schimpff, J. Wade, 1980, Antimicrobial Agents and Chemotherapy.

Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients: a comparison between the combination of moxalactam plus amikacin and ticarcillin plus amikacin.

R. Finley, H. Standiford, P. Wiernik, 1982, The American journal of medicine.

Phase I trial of N-methylformamide (NMF, NSC 3051).

P. O'dwyer, D. V. Van Echo, J. Aisner, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of standard versus pharmacokinetically adjusted amikacin dosing in granulocytopenic cancer patients

R. Finley, P. Wiernik, S. Schimpff, 1982, Antimicrobial Agents and Chemotherapy.

Cytosine arabinoside for localized herpes zoster in patients with cancer: failure in a controlled trial.

P. Wiernik, S. Schimpff, W. Greene, 1974, The Journal of infectious diseases.

Ticarcillin in Combination with Cephalothin or Gentamicin as Empiric Antibiotic Therapy in Granulocytopenic Cancer Patients

S. Landesman, H. Standiford, P. Wiernik, 1976, Antimicrobial Agents and Chemotherapy.

Comparative auditory toxicity of aminoglycoside antibiotics in leukopenic patients.

J. Bender, P. Wiernik, S. Schimpff, 1979, American journal of hospital pharmacy.

The acute leukemias.

W. Cornelis, C. Fortner, D. Christian, 1972, Journal of the American Pharmaceutical Association.

Piperacillin or ticarcillin plus amikacin. A double-blind prospective comparison of empiric antibiotic therapy for febrile granulocytopenic cancer patients.

H. Standiford, P. Wiernik, S. Schimpff, 1981, The American journal of medicine.

Combination Antiemetic Therapy in the Control of Chemotherapy-Induced Emesis

R. Finley, C. Fortner, W. Grove, 1985, Drug intelligence & clinical pharmacy.

Advances in oncology pharmacy practice.

R. Finley, R. Schwartz, Brandon R. Shank, 2015, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Patient treatment on a compassionate basis: documentation of high adverse drug reaction rate.

B. Leyland-Jones, P. O'dwyer, D. Macfarlane, 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

Piperacillin Sodium: Antibacterial Spectrum, Pharmacokinetics, Clinical Efficacy, and Adverse Reactions

R. Finley, S. Schimpff, C. Fortner, 1982, Pharmacotherapy.

Effects of synthetic oxytocin with and without preservatives upon coronary blood flow in the dog.

R. A. Woodbury, E. Manley, C. Fortner, 1969, The Journal of pharmacology and experimental therapeutics.

Hodgkin's disease.

W. Cornelis, C. Fortner, D. Christian, 1973, Journal of the American Pharmaceutical Association.

High-dose methotrexate with folinic acid rescue.

J. Bender, C. Fortner, W. Grove, 1977, American journal of hospital pharmacy.

Role of Vancomycin as a Component of Oral Nonabsorbable Antibiotics for Microbial Suppression in Leukemic Patients

J. Bender, P. Wiernik, S. Schimpff, 1979, Antimicrobial Agents and Chemotherapy.